ZeroStack Corp. operates across two primary business segments: AI-powered asset management focused on decentralized AI infrastructure, and pharmaceutical and medical cannabis distribution. The company distributes a range of pharmaceutical products and medical cannabis items targeting specific health conditions including cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressant medications.
The company was incorporated in 2019 and rebranded from Flora Growth Corp. to ZeroStack Corp. in January 2026. It maintains headquarters in Fort Lauderdale, Florida, and operates with a team of 64 full-time employees. The company is incorporated in Ontario, Canada, and listed on Nasdaq.
The pharmaceutical and cannabis distribution segment represents a significant portion of the company's business operations, though specific revenue breakdowns by segment are not publicly detailed. Geographic reach and revenue tier information regarding the asset management division remains limited in available disclosures.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-43.49 | $-43.49 | -3245.4% | |
| 2024 | $-1.30 | $-1.30 | +83.2% | |
| 2023 | $-7.75 | $-7.75 | — | |
| 2022 | — | — | — |